Sunitix 12.5 Mg (Sunitinib) – 28 Capsules

Sunitix 12.5 Mg (Sunitinib) is a targeted cancer therapy used to treat various types of cancer, including renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). Containing Sunitinib, Sunitix 12.5 mg is a multi-kinase inhibitor that works by blocking multiple molecular pathways that tumors use to grow and spread. This medication offers a critical treatment option for patients with advanced cancers, helping to control tumor growth and improve survival rates.

Sunitix 12.5 mg is indicated for the treatment of:

• Renal Cell Carcinoma (RCC): Sunitix is used as a first-line treatment for advanced RCC, providing a targeted approach that helps control the progression of this cancer.
• Gastrointestinal Stromal Tumors (GIST): Sunitix 12.5 mg is indicated for the treatment of GIST in patients who are resistant to imatinib or who cannot tolerate imatinib therapy.
• Pancreatic Neuroendocrine Tumors (pNET): Sunitix is also used to treat advanced pNET, particularly in cases where the disease is progressive and cannot be treated surgically.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Sunitix 12.5 Mg (Sunitinib) medicine.